Yahoo Suche Web Suche

Suchergebnisse

  1. Suchergebnisse:
  1. Vor 3 Tagen · Verve Therapeutics, Inc. (Nasdaq: VERV) is a clinical-stage genetic medicines company pioneering a new approach to the care of cardiovascular disease, potentially transforming treatment from chronic management to single-course gene editing medicines. The company’s lead programs – VERVE-101, VERVE-102, and VERVE-201 – target genes that have been extensively validated as targets for ...

  2. Vor 3 Tagen · BOSTON, May 31, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing ...

  3. Vor 3 Tagen · BOSTON, May 31, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing...

  4. Vor 3 Tagen · Am 31. Mai 2024 um 13:00 Uhr. Verve Therapeutics, Inc. gab bekannt, dass Troy Lister, Ph.D., der derzeit als Senior Vice President für Forschung und frühe Entwicklung bei Verve tätig ist, mit Wirkung vom 21. Juni 2024 zum Chief Scientific Officer ernannt wurde.

  5. Vor 5 Tagen · The Verve - Bitter Sweet SymphonyStream/Download : https://TheVerve.lnk.to/Essentials[Follow The Verve]https://www.facebook.com/theverve/https://twitter.com/...

    • 8 Min.
    • 1
    • BGM Lyrics
  6. Vor 3 Tagen · VERVE THERAPEUTICS INC. WKN: A3CSHT | ISIN: US92539P1012 | Ticker-Symbol: NASDAQ. 31.05.24. 21:59 Uhr. 5,185 US-Dollar. +0,045. +0,88 % Nachrichten. Analysen. Kurse. Chart. Branche....

  7. Vor 5 Tagen · It’s that time of the year again - introducing our brand-new Verve Awards for 2024. But this time we’ve evolved them... The aim of the Verve Awards remains the same: to shine a spotlight on the amazing people and initiatives that are happening in financial services, especially those that are rarely in the headlines (but.